Outlook on the Commercial Bioprocessing Global Market to 2025 - Key Trends, Predictions and Preferences
Dublin, Dec. 08, 2021 (GLOBE NEWSWIRE) -- The "Commercial Bioprocessing Market Outlook" report has been added to ResearchAndMarkets.com's offering.
Biological drugs have transformed the practice of medicine in a relatively short period of time due to their ability to bind to specific targets within the body. This report provides an overview of the current market dynamics for commercial bioprocessing as well as an outlook on what our survey respondents - all outsourced bioprocessing decision-makers at sponsor organizations with commercialized products - predict the marketplace will look like five years from now.
Pre-commercial biologic drug producers can learn from what their counterparts with commercialized biologics have to say about their preferences and pain-points as they move down the development pipeline. Key statistics include utilization rates of the four main production systems available to produce proteins, the proportion of respondents' marketed biologics based off each development platform, which platforms are more likely to be outsourced, and a breakdown of annual outsourced expenditure by platform.
What You Will Learn:Drug Developers:
Gain insight into where the biologics industry is heading over the next five years with respect to protein expression systems utilized and types of biologics in the development
Understand the CMO usage patterns of industry peers to identify whether additional outsourcing advantages can be obtained for your organization
Learn the criteria used by peers to help scientifically and strategically evaluate CMOs for bioprocessing projects
CDMOs:
Pinpoint which CMO attributes have led to successful outsourcing relationships, those that have caused service providers to lose bids and what truly drives sponsor satisfaction, then internally assess your company on these metrics
Identify changes in demand for outsourced activities and services in order to prepare for future needs
Better position your company to win business by understanding the dynamics of different buyer groups and developing targeted marketing to speak directly to their unique needs
Major Topics:
Market Dynamics
Service Provider Selection and Perceptions
Trends, Predictions and Preferences
Study Data
Demographics
Key Topics Covered:
1. Introduction
2. Methodology
3. Respondent Demographics
Participant Geography
Participant Company Size
4. Major Sections
5. Market Dynamics
Primary Section Takeaways
Biologic Assets
Biologics by Type
Biologics by Therapeutic Area
Outsourcing Drivers
Bioprocessing Project & CMO Volume
Bioprocessing Project & CMO Volume in 2025
Production Systems in Use
6. Service Provider Selection and Perceptions
Primary Section Takeaways
Use of Consultants
Department Influence on CMO Selection
Top 5 CMO Selection Attributes
CMO Satisfaction Drivers
Top 5 Reasons CMOs Lose Bids
Preferred Provider Use
CMO Familiarity
CMO Leadership, Proposal Volume, Use, and Preference
Top Reasons for Service Provider Preference
7. Trends, Predictions and Preferences
Primary Section Takeaways
Biologics Market Growth Drivers
Reactor Technology Influence on CMO Selection Reactor Preference
In-house vs Outsourced Bioprocessing by Region
Top Five Reasons for Bioprocessing in China
Greatest Challenges When Outsourcing Bioprocessing
8. Study Data
Biologic Assets
Use of Consultants
Bioprocessing Project Volume
Motivations for Outsourcing Bioprocessing
Outsourced Bioprocessing Current and 5 Years Out
In-house Bioprocessing by Geographic Location
Outsourced Bioprocessing by Geographic Location
Bioprocessing in China
Biologics in Development by Type
Biologics in Development by Therapeutic Area
Production Methods for Biologics in Development
Biologics Pipeline by Production Platform
In-house vs Outsourced Development Work
Likelihood of Outsourcing Biologics in Development by Type
Marketed Biologics by Type
Marketed Biologics by Therapeutic Area
Production Methods for Marketed Biologics
Marketed Products by Production Platform
In-house vs Outsourced Commercial Manufacturing
Likelihood of Outsourcing Marketed Biologics by Type
Marketed Biologics in 2025 by Type
Marketed Biologics in 2025 by Therapeutic Area
Production Methods Utilized in 2025
Biologics Portfolio in 2025 by Production Platform
In-house vs Outsourced Manufacturing in 2025
Department Influence on CMO Selection
CMO Selection Attributes
Service Provider Satisfaction Drivers
Reasons Service Providers Lose Bids
Number of CMOs Used to Meet Bioprocessing Needs
Use of Preferred Providers
Number of Preferred Providers
Difficulty in Using a Non-Preferred Provider
Frequency of Modifying the Preferred Provider List
Service Provider Familiarity
Bioprocessing Leaders
Service Provider Consideration
Service Provider Use
Service Provider Preference
Top Reasons Expressed for Service Provider Preference - Unprompted
Verbatim Responses for Service Provider Preference
Annual Outsourced Bioprocessing Spend
Estimated Annual Outsourced Bioprocessing Spend in 2025
Outsourced Expenditure by Production Platform
Reactor Technology Influence on CMO Selection
Reactor Preference
Biologics Market Growth Drivers
9. Demographics
Company Type
Headquarters Location
Office Location
Decision-making Responsibility
Outsourcing Involvement
Contract Manufacturer Involvement
10. About the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/mkmf9z
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900